Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

RheumPAC: It’s Not About Politics

James Engelbrecht, MD  |  Issue: July 2011  |  July 12, 2011

Dr. Engelbrecht

The best thing about RheumPAC is that it’s not political.

That statement will usually get the attention of the individual or group I’m soliciting for contributions to RheumPAC. Everyone “knows” that political action committees (PACs) are in that sullied, nasty business of elections, ideologies, and politics. In fact, the most common excuse for not contributing to RheumPAC, other than apathy perhaps, is that “you give money to someone I could never support in a million years!” That is political thinking and rationale.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Your RheumPAC is about getting an apolitical rheumatology message to policy makers and lawmakers. RheumPAC could not care less about the ideology, philosophy, or party affiliation of the elected official.

Our elected representatives by and large are sincerely interested in making informed decisions based on sound information and data. They are also interested in being re-elected and, as such, must run campaigns, which cost real dollars. By contributing to campaigns, we can gain some access to the elected officials, allowing us to educate them and their staffs on rheumatology issues. This has often led to the development of a trusting relationship well beyond any dollars contributed. We become their “go-to” source for reliable information on arthritis and rheumatology issues. This has led to writing and sponsorship of legislation directly impacting rheumatology. Two great examples are Rep. Shelly Berkley (D-NV) and Rep. Michael Burgess, MD (R-Texas). We have had longstanding, solid, and trusting relationships with both representatives, and they continue to champion the cause of access to bone density measurements and osteoporosis treatment.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Think of it this way: If the government had no involvement in healthcare policy, research, or funding of healthcare, there would be scant reason for having an ACR Government Affairs Committee or RheumPAC. The fact is, however, that our federal government is the majority player in all aspects of medicine and healthcare.

Decisions that directly and indirectly affect you and your patients are made by the elected officials. It is imperative that we have access to those elected representatives. Access depends on two things—constituency and money. The ACR works to identify and cultivate relationships between members of Congress and our physician and patient advocates, but providing campaign donations through RheumPAC opens doors for us as well. Your dollars contributed to RheumPAC go entirely to getting the rheumatology message to our representatives. It’s not politics, its RHEUMATOLOGY!

So, if the P in RheumPAC bothers you, just substitute patients or physicians—or perhaps profession would be a better P. Plus, there is always proponent, protagonist, or promoter of rheumatology. Don’t let the political stop you from contributing generously and annually to RheumPAC. Your specialty and your patients need you to be there for them.

Page: 1 2 | Single Page
Share: 

Filed under:From the CollegeLegislation & Advocacy Tagged with:AdvocacyCongressLegislationrheumatologyRheumPAC

Related Articles

    I RheumPAC, Do You?

    September 1, 2009

    For many years, the ACR board of directors and Government Affairs Committee have done exemplary work in keeping members abreast of legislative regulatory issues that affect all aspects of rheumatology, including patient and physician/healthcare professional issues, education, and research. Through advocacy, the ACR advances rheumatology and fosters excellence in the care of people with, or at risk for, arthritis and rheumatic and musculoskeletal diseases. One might say that advocacy is a cornerstone of this organization.

    A Huge Thank You to 251 People

    March 18, 2011

    RheumPAC supporters are helping to advance rheumatology

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences